Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f2d3599fb8f8f479dba95ca9bb504884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7b7d77f47e4759b23d94617cc58eb66f |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-22 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-357 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 |
filingDate |
2008-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_26b3a503d509cf3de0b6027d8f526271 |
publicationDate |
2009-10-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-2009120189-A1 |
titleOfInvention |
Use of benzo-fused heterocycle sulfamide derivatives for the treatment of anxiety |
abstract |
The present invention is a method for the treatment of anxiety and related disorders comprising administering to a subject in need thereof a therapeutically effective amount of one or more novel benzo-fused heterocycle sulfamide derivatives of formula (I) and formula (II) as herein defined. The present invention is directed to a method for the treatment of anxiety and related disorders, which includes mono-therapy and alternatively, co-therapy with at least one anxiolytic. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8609849-B1 |
priorityDate |
2008-03-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |